Silence Therapeutics is developing a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with...
Danakali Ltd (ASX:DNK) is developing the Colluli Potash Project, a world class greenfield SOP development project.
Join our audience of astute high net worth investors, fund managers, private client brokers and analysts
Look beyond the numbers and meet the people creating the value for shareholders
Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story
Watch the event afterwards on our YouTube channel
One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.